Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Radiofrequency Ablation for Liver Metastases after Transarterial Chemoembolization: A Systemic Analysis

  • Xu, Chuan (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Lv, Peng-Hua (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Huang, Xin-En (Department of Chemotherapy, Jiangsu Cancer Hospital, Nanjing Medical University) ;
  • Wang, Shu-Xiang (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Sun, Ling (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University) ;
  • Wang, Fu-An (Department of Interventional Radiology, Subei People's Hospital of Jiangsu Province, Clinical Hospital of Yangzhou University)
  • Published : 2015.07.13
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This systemic analysis was conducted to evaluate tumor recurrence rate and one-year survival rate for patients with liver metastases received radiofrequency ablation after transarterial chemoembolization and introduce a new method of radiofrequency ablation by puncture navigation technology for single liver metastases after transarterial chemoembolization. Materials and Methods: Clinical studies evaluating tumor recurrence rate and one-year survival rate. Appling the innova trackvision software to process one liver metastases received transarterial chemoembolization and using radiofrequency ablation by puncture navigation technology to treat the liver metastases. Results: 3 clinical studies which including 235 patients with liver metastases after transaeterial chemoembolization were considered eligible for inclusion. Systemic analysis suggested that tumor recurrence rate was 23% (54/235), one-year survival rate was 76% (178/235). The new procedure was performed successfully and the patient received a good prognosis. Conclusions: This systemic analysis suggests that radiofrequency ablation is a good method for liver metastases after transarterial chemoembolization and could receive a relatively good prognosis.

Keywords

References

  1. Bloomston M, Binitie O, Fraiji E, et al (2002). Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg, 68, 827-31.
  2. Georgiades C, Geschwind JF, Harrison N, et al (2012). Lack of response after initial chemoembolization for hepatocellular carcinoma: dose it predict failure of subsequent treatment? Radiology, 265, 115-23. https://doi.org/10.1148/radiol.12112264
  3. Germani G, Pleguezuelo M, Gurusamy K, et al (2010). Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatoceluller carcinoma: a meta-analysis. J Hepatol, 52, 380-88. https://doi.org/10.1016/j.jhep.2009.12.004
  4. Jonggi C, Ju HS, Yong MS, et al (2014). Clinical significance of the best response during repeated transarterial chemoembolization in the treatment of hepatocellular cacinama. J Hepatol, 60, 1212-18. https://doi.org/10.1016/j.jhep.2014.01.014
  5. Kang HK, Jeong YY, Choi JH, et al (2002). Three-dimensional multi-detector row CT portal venography in the evaluation of portosystemic collateral vessels in liver cirrhosis. Radio Graphics, 22, 1053-61.
  6. Kim YS, Lim HK, Rhim H, et al (2013). Tenyear outcomes of percutaneous radiofrequency ablation as .rst-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol, 58, 89-97. https://doi.org/10.1016/j.jhep.2012.09.020
  7. Kosuke M, Toru B, Aikira C, et al (2013). Hepatic resection combined with radiofrequency ablation for initially unresectable colorectal liver metastases after effective chemotherapy is a safe procedure with a low incidence of recurrence. Am Surg, 83, 1527-31.
  8. Lewandowski RJ, Geschwind JF, Liapi E, et al (2011). Transcatheter intraarterial therapies: rationale and overview. Radiology, 259, 641-57. https://doi.org/10.1148/radiol.11081489
  9. Lupo L, Panzera P, Giannelli G, et al (2007). Single hepatocellular carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection? HPB (Oxford), 9, 429-34. https://doi.org/10.1080/13651820701713758
  10. Mark B, Odion B, Elie F, et al (2002). Transcatheter arterial chemoembolization with or without Radiofrequency Ablation in the Management of Patients with Advanced Hepatic Malignancy. Am Surg, 68, 827-31
  11. Martin RC, Robbins K, Tomalty D, et al (2009). Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. World J Surg Oncol, 7, 80-92. https://doi.org/10.1186/1477-7819-7-80
  12. Michael V, Ali H, Thomas JW, et al (2014). Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology, 60, 192-201. https://doi.org/10.1002/hep.27057
  13. Nakai M, Shiraki T, Higashi K, et al (2005). Low-output radiofrequency ablation combined with transcatheter arterial oilychemoembolization for hepatocellur carcinoma. Nihon Lgaku Hoshasen Gakkai Zasshi, 65, 124-26.
  14. Pellerin O, Lin M, Bhagat N, et al (2013). Can C-arm cone-beam CT detect a micro-embolic effect after TheraSphere radioembolization of neuroendocrine and carcinoid liver metastasis? Cancer Biother Radiopharm, 28, 459-65. https://doi.org/10.1089/cbr.2012.1390
  15. Salem R, Miller FH, Yaghmai V, et al (2013). Response assessment methodologies in hepatocellular carcinoma: complexities in the era of local and systemic treatments. J Hepatol, 58, 1260-62.
  16. Tacher V, Lin M, Chao M, et al (2013). Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI. Acad Radiol, 20, 446-52. https://doi.org/10.1016/j.acra.2012.11.009
  17. Vigano L, Ferrero A, Lo Tesoriere R, et al (2008). Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol, 15, 2458-64. https://doi.org/10.1245/s10434-008-9935-9
  18. Yang HJ, Lee JH, Lee DH, et al (2014). Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting. Radiology, 271, 909-18. https://doi.org/10.1148/radiol.13131760
  19. Zhi VF, Francesco P, Laurence N, et al (2012). Combined Hepatic Arterial Embolization and Hepatic Ablation for Unresectable Colorectal Metastases to the liver. Am Surg, 78, 1243-48.

Cited by

  1. Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.413
  2. A Clinical Study on Juheli (Recombinant Human Interleukin - 11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.485